Abstract: New flavonoidal glucosides leufolins A (1) and B (2), have been isolated from the ethyl acetate soluble fraction of the whole plants of Leucas urticifolia. Their structures were elucidated on the basis of extensive analysis of nuclear magnetic resonance (1D and 2D NMR) spectral data. Both of these compounds exhiited significant inhibitory potential against the enzyme butyrylcholinesterase.
Introduction
The genus Leucas, belonging to the family Lamiaceae, comprises about 100 species. In the IndoPakistani subcontinent, the genus is represented by 35 species which are mostly herbs or undershrubs found in temperate or hilly regions [1] . L. urticifolia is an annual herb which is commonly found in Karachi and other parts of Sind province of Pakistan. It is astringent, stimulant, haemostatic, anthelmintic and diuretic. The plant is also used for the treatment of diarrhea, dysentery, uterine haemorrhages, dropsy, gravel, cystitis, calculus, bronchial catarrh, skin diseases, fever and various types of mental disorders [2] [3] . Our literature survey revealed that no phytochemical work has been carried out on this species so far. An ethanolic extract of L. urticifolia showed strong toxicity in the brine shrimp lethality test. On fractionation of the extract, the major toxicity was located in the EtOAc fraction. This prompted us to undertake bioassay directed isolation studies on this fraction, which resulted in the isolation and structure elucidation of two new bioactive flavonoidal glucosides named as leufolins A (1) and B (2), respectively.
Results and Discussion
The methanolic extract of shade-dried whole plant material of L. urticifolia was evaporated in vacuo, suspended in H 2 O, and successively partitioned with n-hexane, EtOAc, and n-BuOH. As a result of a series of column chromatographic techniques leufolins A (1) and B (2) were isolated from the EtOAc fraction as described in the Experimental.
Leufolin A (1) was isolated as a light yellow amorphous solid which gave a violet coloration with ferric chloride and was recognized as a flavonoid glucoside from its positive reaction with Molish and Shinoda reagents [4] . The molecular formula was determined to be C 30 4 were typical of C-2, C-3 and C-4 carbons of the flavanone skeleton [7] . J correlation with signal at C-2'' (δ 74.5). Similarly, p-hydroxycinnamate moiety was confirmed by 3 J correlations of both Ha-6'' and Hb-6'' with carbonyl of the ester moiety at δ 169.0. The absolute configuration at C-2 was assigned S on the basis of CD spectrum which showed similar Cotton effects as reported in the literature for related flavonoids [8] [9] . On the basis of these evidences, the structure of 1 could be assigned as {6-[4- The 1 H-NMR spectrum was similar to that of compound 1, except now the presence of a trisubstituted double bond of the flavone moiety at δ 6.89 (1H, s) and a variation in the chemical shifts of meta coupled protons of the ring A was noted (Table 1 ). In the 13 C-NMR spectrum olefinic carbons appeared at δ 164.9 and 104.7, which were characteristic for C-2 and C-3 of flavones. On the basis of this evidence, coupled with HMQC and HMBC correlations, the structure of leufolin B (2) could be assigned as {6-[4-(6,8-dihydroxy-4-oxo-4H-chromen-2-yl)phenoxy]-3,5-dihydroxytetrahydro-2H-pyran-2-yl}methyl-(E)-3(4-hydroxyphenyl)-2-propenoate. It is the positional isomer of the acylated flavonoidal glucoside earlier reported from Thymus serpyllum [11] and Palhinhaea cernua [10] , respectively.
Biological Activity
Cholinesterases are enzymes that share extensive sequence homology and distinct substrate specificity and inhibition sensitivity. Cholinesterases are potent target for the symptomatic treatment of Alzheimers disease and related dementia. It has been found that butyrylcholinesterase (BChE) inhibition is an effective tool for the treatment of AD and related dementias [12] . It has been found that BChE is found in significantly higher quantities in Alzheimer plaques than in plaques of normal agerelated non-demented brains. It is general viewed as a back up for the homologus acetylcholinesterase and to act as a scavenger for anticholinesterase compounds [13] .
Eserine was used as positive control in BChE inhibitory assay for 1 and 2. From the results (Table  2) it is obvious that both leufolins A (1) and B (2) 
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UV and IR spectra were recorded on Hitachi UV-3200 and JASCO 302-A spectrophotometers, respectively.
1 H-and 13 C-NMR spectra were recorded at 400 MHz and 100 MHz, respectively, on a Bruker AM-400 spectrometer with tetramethylsilane (TMS) as a standard. The 2D-NMR spectra were recorded on a Bruker AMX-500 NMR spectrometer. Optical rotations were measured on a JASCO DIP-360 digital polarimeter using a 10 cm tube. Mass spectra (EI, FAB and HREIMS) were measured on Finnigan MAT 12 and MAT 312 spectrometers and ions are given in m/z (%). TLC was performed on precoated silica gel F 254 plates; the detection was done at 254 nm and by spraying with ceric sulphate reagent. Silica gel (E-Merck, 230-400 mesh) was used for column chromatography. Melting points were determined on a Gallenkamp apparatus and are uncorrected. For enzyme inhibition assay all the chemicals were purchased from Sigma Chemical Company (St. Louis, MO, U.S.A.).
Plant Material
The whole plant of Leucas urticifolia Vahl. was collected from Karachi, Pakistan in July 2003 and identified by Dr. Javed Zaki, Plant Taxonomist, Department of Botany, University of Karachi, where a voucher specimen (BKU 101) has been deposited.
Extraction and Isolation
The air dried whole plant material (10 kg) was extracted with methanol (3 × 30 L) at room temperature. The extract was evaporated to yield the residue (500 g), which was divided into n-hexane (80 g), chloroform (30 g), ethyl acetate (8 g), n-butanol (270 g) and water (100 g) soluble fractions. The ethyl acetate soluble fraction, which showed major toxicity in a brine shrimp lethality test, was subjected to column chromatography over silica gel eluting with mixtures of dichloromethane and methanol in increasing order of polarity to obtain three major fractions A, B and C. The fraction B obtained from CHCl 3 -MeOH (5:5) was again chromatographed over silica gel using CHCl 3 -MeOH (9:1) as eluent to afford two successive fractions B A and B B . Column chromatography of subfraction B B and elution with CHCl 3 -MeOH (4:6) afforded leufolin A (1, 15 mg). On the other hand, the fraction C, obtained from CHCl 3 -MeOH (3:7), yielded leufolin B (2, 13 mg). Table 1 ; important HMBC correlations are illustrated in Figure 2 . Table 1 .
{6-[4-(5, 7-dihydroxy-4-oxo-3, 4-dihydro-2H-chromen-2-yl) phenoxy]-3, 4, 5-trihydroxy tetrahydro-2H-pyran-2-yl} methyl (E)-3-(4-hydroxyphenyl)-2-propenoate (Leufolin
{6-[4-(6, 8-dihydroxy-4-oxo-4H-chromen-2-yl) phenoxy]-3, 5-dihydroxytetrahydro-2H-pyran-2-yl} methyl(E)-3(4-hydroxyphenyl)-2-propenoate (Leufolin
Acid Hydrolysis
Compound 1 (15 mg) was refluxed in 10 % HCl for 40 minutes. The cooled reaction mixture was neutralized with 10 % NaOH. The resulting aqueous mixture was extracted with ethyl acetate. The aqueous phase was concentrated and D-glucose was identified by Co-TLC using an 11:2:2:2 EtOAcMeOH-H 2 O-HOAc solvent system and by the sign of its optical rotation ([α] D = +52.2). It was further confirmed by comparing the retention time of its TMS ether with a standard sample by GC. The residue recovered from the organic phase was a binary mixture of two components which could be separated through preparative TLC using a 1:3 EtOAc-n-hexanesolvent system and identified as naringenin [14] (needles, mp 255-256 °C) and p-coumaric acid (amorphous solid, mp 210-213 °C).
In vitro Butyrylcholinesterase inhibition assay
Butyrylcholinesterase inhibiting activity was measured by the spectrophotometric method previously reported in the literature [15] . Butyrylthiocholine chloride was used as substrate to assay butyrylcholinesterase. The reaction mixture containing 100 mM sodium phosphate buffer (pH 8, 150 µL), DTNB (10 µL), test compound solution (10 µL) and butyrylcholinesterase solution (20 µL) was mixed and incubated for 15 minutes (25 °C). The reaction was then initiated by the addition of butyrylthiocholine (10 µL). The hydrolysis of butyrylthiocholine was monitored by the formation of yellow 5-thio-2-nitrobenzoate anions as the result of the reaction of DTNB with thiocholine, released by the enzymatic hydrolysis of butyrylthiocholine at a wavelength of 412 nm (15 min.). Test compounds and the positive control (eserine) were dissolved in EtOH. All the reactions were performed in triplicate in 96-well micro-titre plates in SpectraMax 340 (Molecular Devices, U.S.A.). The percentage (%) inhibition was calculated as follows (E -S)/E × 100, where E is the activity of the enzyme without test compound and S is the activity of enzyme with test compound.
Determination of IC 50 values
The concentrations of test compound and positive control that inhibited the hydrolysis of substrate (butyrylthiocholine) by 50 % (IC 50 ) were determined by monitoring the effect of various concentrations of these compounds in the inhibition value assays. The IC 50 values were then calculated as standard mean error of five assays using the EZ-Fit Enzyme Kinetics program (Perrella Scientific Inc., Amherst, MA, U.S.A.).
